{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:08:14Z","timestamp":1784261294114,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY18H310005"],"award-info":[{"award-number":["LY18H310005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227595","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T13:26:57Z","timestamp":1578922017000},"page":"e0227595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017"],"prefix":"10.1371","volume":"15","author":[{"given":"Lingyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-2290","authenticated-orcid":true,"given":"Zhenwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"pone.0227595.ref001","first-page":"668","article-title":"Glaucoma","volume":"93","author":"D Gupta","year":"2016","journal-title":"Am Fam Physician"},{"key":"pone.0227595.ref002","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"H Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"pone.0227595.ref003","first-page":"1","article-title":"National and subnational prevalence and burden of glaucoma in China: A systematic analysis","volume":"7","author":"P Song","year":"2017","journal-title":"J Glob Health"},{"key":"pone.0227595.ref004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: A systematic review for the U.S. preventive services task force","volume":"158","author":"MV Boland","year":"2013","journal-title":"Ann Intern Med"},{"key":"pone.0227595.ref005","unstructured":"National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. 2017. https:\/\/www.nice.org.uk\/guidance\/ng81."},{"key":"pone.0227595.ref006","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The Pathophysiology and Treatment of Glaucoma: a review","volume":"311","author":"RN Weinreb","year":"2014","journal-title":"JAMA"},{"key":"pone.0227595.ref007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: Relative value and place in therapy of available drug treatments","volume":"5","author":"D Sambhara","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"pone.0227595.ref008","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/YIC.0000000000000278","article-title":"Trends of antidementia drugs use in outpatients with Alzheimer\u2019s disease in six major cities of China: 2012\u20132017","volume":"34","author":"L Yu","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"pone.0227595.ref009","first-page":"201","article-title":"Current status of parenteral nutrition and enteral nutrition application: an assessment of nutritional prescriptions from 59 hospitals in the People \u2018 s Republic of China","volume":"11","author":"G Han","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"pone.0227595.ref010","first-page":"1","article-title":"Geographical variation in glaucoma prescribing trends in England 2008\u20132012: An observational ecological study","volume":"6","author":"JS Heng","year":"2016","journal-title":"BMJ Open"},{"key":"pone.0227595.ref011","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2011.02.050","article-title":"Prevalence of glaucoma in a rural northern China adult population: A population-based survey in Kailu County, Inner Mongolia","volume":"118","author":"W Song","year":"2011","journal-title":"Ophthalmology"},{"key":"pone.0227595.ref012","first-page":"1","article-title":"Prevalence of treatment with glaucoma medication in Scotland, 2010\u20132017","volume":"0","author":"AP Rotchford","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"pone.0227595.ref013","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis","volume":"121","author":"YC Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"pone.0227595.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7642049","article-title":"Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database","volume":"2017","author":"M Sakamoto","year":"2017","journal-title":"J Ophthalmol"},{"key":"pone.0227595.ref015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajo.2014.04.026","article-title":"The maccabi glaucoma study: Prevalence and incidence of glaucoma in a large Israeli health maintenance organization","volume":"158","author":"H Levkovitch-Verbin","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"pone.0227595.ref016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0032-1327946","article-title":"Mechanisms, clinical profile and role of prostaglandin and prostamide analogues in antiglaucomatous therapy","volume":"230","author":"A Yu","year":"2013","journal-title":"Klin Monbl Augenheilkd"},{"key":"pone.0227595.ref017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00002512-200320080-00005","article-title":"Latanoprost: An update of its use in glaucoma and ocular hypertension","volume":"20","author":"CM Perry","year":"2003","journal-title":"Drugs and Aging"},{"key":"pone.0227595.ref018","doi-asserted-by":"crossref","first-page":"e96852","DOI":"10.1371\/journal.pone.0096852","article-title":"Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucoma","volume":"9","author":"SM Li","year":"2014","journal-title":"PLoS One"},{"key":"pone.0227595.ref019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00061198-200110000-00010","article-title":"Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension","volume":"10","author":"I Goldberg","year":"2001","journal-title":"J Glaucoma"},{"key":"pone.0227595.ref020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/ICU.0000000000000346","article-title":"New classes of glaucoma medications","volume":"28","author":"EM Schehlein","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"pone.0227595.ref021","first-page":"S279","article-title":"Current therapeutic options and treatments in development for the management of primary open-angle glaucoma","volume":"23","author":"JM Liebmann","year":"2017","journal-title":"Am J Manag Care"},{"key":"pone.0227595.ref022","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/eye.2014.114","article-title":"Glaucoma prescribing trends in England 2000 to 2012","volume":"28","author":"AJ Connor","year":"2014","journal-title":"Eye"},{"key":"pone.0227595.ref023","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s12325-017-0593-9","article-title":"Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study","volume":"34","author":"M Fajgenbaum","year":"2017","journal-title":"Adv Ther"},{"key":"pone.0227595.ref024","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archopht.125.4.454","article-title":"Comparison of initial intraocular pressure response with topical \u03b2-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the ocular hypertension treatment study","volume":"125","author":"SL Mansberger","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"pone.0227595.ref025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"R Conlon","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"pone.0227595.ref026","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.2174\/1381612821666150909095553","article-title":"Controversies in Glaucoma: Current Medical Treatment and Drug Development","volume":"21","author":"C Bucolo","year":"2015","journal-title":"Curr Pharm Des"},{"key":"pone.0227595.ref027","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archophthalmol.2010.131","article-title":"Meta-analysis of the efficacy and safety of \u03b12-adrenergic agonists, \u03b2-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs","volume":"128","author":"AP Tanna","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"pone.0227595.ref028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0161-6420(99)90147-1","article-title":"The Collaborative Initial Glaucoma Treatment Study: Study design, methods, and baseline characteristics of enrolled patients","volume":"106","author":"DC Musch","year":"1999","journal-title":"Ophthalmology"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0230694","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T13:27:22Z","timestamp":1578922042000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227595"}},"subtitle":[],"editor":[{"given":"Naeti","family":"Suksomboon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227595","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0230694","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}